Article Figures & Data
Figures
Tables
Variable n (%) Exact age, mean±SD 34.43±6.73 Gender Male 209 (52.6) Female 188 (47.4) Age group (in years) 27-36 306 (77.1) 37-46 68 (17.1) 47-56 23 (5.8) Nationality Saudi 201 (50.6) Non-Saudi 196 (49.4) Education qualification Bachelors 260 (65.5) Masters 101 (25.4) PhD 36 (9.1) Occupation Physician 87 (21.9) Pharmacist 178 (44.8) Nurse 59 (14.9) Teacher/preceptor 22 (5.5) Other health care professional 51 (12.8) SD: standard deviation
Variables n (%) Severity of vaccine related side effects Major 57 (14.4) Minor 238 (59.9) No side effect reported 102 (25.7) Minor side effects Low grade fever, chills & headache 85 (35.7) Pain at the injection site 73 (30.7) Myalgia and arthralgia 33 (13.9) Fatigue & tiredness 47 (19.6) Major side effects High grade fever 47 (82.4) Dyspnea 8 (14.0) Anxiety 2 (3.5) Timeline after which the side effects were experienced <12 hours 23 (7.8) 12-24 hours 234 (79.3) 24-48 hours 38 (12.9) Medical assistance due to minor side effects Yes 0 (0.0) No 238 (100) Medical assistance due to major side effects Yes 7 (12.3) No 50 (87.7) Medication taken to treat minor side effects Yes 172 (72.2) No 66 (27.7) Medication taken to treat major side effects Yes 57 (100) No 0 (0.0) Complete recovery after medical assistance Yes 7 (100) No 0 (0.0) Days to recover after medical assistance 1-2 5 (71.4) >2 2 (28.6) Variables No side effect reported Minor Major Chi-square (χ2) P-value Gender Male 89 (42.6) 106 (50.7) 14 (6.7) 73.32 <0.001 Female 13 (6.9) 132 (70.2) 43 (22.9) Age group (in years) 27-36 70 (22.9) 190 (62.1) 46 (15.0) 10.19 0.03* 37-46 24 (35.3) 33 (48.5) 11 (16.2) 47-56 8 (34.8) 15 (65.2) 0 (0.0) Nationality Saudi 70 (34.8) 114 (56.7) 17 (8.5) 23.80 <0.001 Non-Saudi 32 (16.3) 124 (63.3) 40 (20.4) Educational qualification Bachelors degree 65 (25.0) 156 (60.0) 39 (15.0) 5.22 0.27 Masters degree 24 (23.8) 66 (65.3) 11 (10.9) Doctorate 13 (36.1) 16 (44.4) 7 (19.4) Occupation Physician 26 (30.2) 52 (60.5) 8 (9.3) 10.60 0.10 Pharmacist 37 (21.6) 113 (66.1) 21 (12.3) Nurse 18 (32.1) 27 (48.2) 11 (19.6) Other HCP 21 (25.0) 46 (54.8) 17 (20.2) Type of vaccine Covishield (Oxford-AstraZeneca) 34 (11.7) 208 (71.5) 49 (16.8) 112.08 <0.001 Pfizer (Pfizer BioNTech) 68 (64.2) 30 (28.3) 8 (7.5) Comorbidities/current medical condition Diabetes 4 (30.8) 8 (61.5) 1 (7.7) 3.68 0.72* Hypertension/cardiac disorders 7 (43.8) 7 (43.8) 2 (12.5) Others 7 (21.2) 22 (66.7) 4 (12.1) No serious medical condition 84 (25.1) 201 (60.0) 50 (14.9) Known allergies No allergies 96 (27.8) 223 (64.6) 26 (7.5) 99.69 <0.001 Allergies present 6 (11.5) 15 (28.8) 31 (59.6) Current medications Currently not on any medications 77 (21.5) 232 (64.8) 49 (13.7) 40.30 <0.001 Currently taking medications 25 (64.1) 6 (15.4) 8 (20.5) Previous COVID-19 infection Yes 95 (27.1) 209 (59.7) 46 (13.1) 5.49 0.06 No 7 (14.9) 29 (61.7) 11 (23.4) Values are presented as numbers and percentages (%). HCP: health care professional, * Fisher exact (p<0.05)
- Table 4
- Binary logistic regression between severity of side effects and selected variables.
Determinants AOR 95% CI P-value Lower Upper Gender Male 3.72 1.79 7.75 <0.001 Female Ref Name of the vaccine Covishield 1.07 0.43 2.65 0.89 Pfizer Ref Known allergies Yes 16.29 7.76 34.17 <0.001 No Ref Nationality Saudi 2.51 1.24 5.09 0.01 Non-Saudi (p<0.05) Ref CI: confidence interval, AOR: adjusted odds ratio, ref: reference category